BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping

Nature Structural and Molecular Biology

Volumn 17, Issue 12, 2010, Pages 1461-1469

  Badie, Sophie ^a   Escandell, Jose M ^a   Bouwman, Peter ^b   Carlos, Ana Rita ^a   Thanasoula, Maria ^c   Gallardo, Maria M ^d   Suram, Anitha ^c   Jaco, Isabel ^c   Benitez, Javier ^d   Herbig, Utz ^c   Blasco, Maria A ^c   Jonkers, Jos ^b   Tarsounas, Madalena ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; RAD51 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMOSOME REPLICATION; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE DELETION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

ANIMALS; BRCA2 PROTEIN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA REPAIR; G2 PHASE; GENE DELETION; GENOMIC INSTABILITY; MICE; RAD51 RECOMBINASE; S PHASE; TELOMERE;

EID: 78649837330     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1943     Document Type: Article

References (46)

1. Narod, S.A. & Foulkes, W.D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 4, 665-676 (2004).
2. Evers, B. & Jonkers, J. Mouse models of BRCA1 and BRCA2 defciency: past lessons, current understanding and future prospects. Oncogene 25, 5885-5897 (2006).
3. Thorslund, T. & West, S.C. BRCA2: a universal recombinase regulator. Oncogene 26, 7720-7730 (2007).
4. Venkitaraman, A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 4, 461-487 (2009).
5. Nagaraju, G. & Scully, R. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst.) 6, 1018-1031 (2007).
6. Tsang, E. & Carr, A.M. Replication fork arrest, recombination and the maintenance of ribosomal DNA stability. DNA Repair (Amst.) 7, 1613-1623 (2008).
7. Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002).
8. Cesare, A.J. & Reddel, R.R. Telomere uncapping and alternative lengthening of telomere. Mech. Ageing Dev. 129, 99-108 (2008).
9. Verdun, R.E. & Karlseder, J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127, 709-720 (2006).
10. West, S.C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4, 1-11 (2003).
11. Thacker, J. & Zdzienicka, M.Z. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst.) 2, 655-672 (2003).
12. Badie, S. et al. RAD51C facilitates checkpoint signalling by promoting CHK2 phosphorylation. J. Cell Biol. 185, 587-600 (2009).
13. Palm, W. & de Lange, T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 16.1-16.34 (2008).
14. Tarsounas, M. et al. Telomere maintenance requires the RAD51D recombination/ repair protein. Cell 117, 337-347 (2004).
15. Jaco, I. et al. Role of mammalian Rad54 in telomere length maintenance. Mol. Cell. Biol. 23, 5572-5580 (2003).
16. Tarsounas, M. & West, S.C. Recombination at mammalian telomeres: an alternative mechanism for telomere protection and elongation. Cell Cycle 4, 672-674 (2005).
17. Maser, R.S. & DePinho, R.A. Telomeres and the DNA damage response: why the fox is guarding the henhouse. DNA Repair (Amst.) 8-9, 979-988 (2004).
18. Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565-569 (2002).
19. Jacobs, J.J.L. et al. Senescence bypass screen identifes TBX2, which represses Cdkn2a(p19ARF) and is amplifed in a subset of human breast cancers. Nat. Genet. 26, 291-299 (2000).
20. Silver, D.P. & Livingston, D.M. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol. Cell 8, 233-243 (2001).
21. Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418-425 (2001).
22. Herrera, E. et al. Disease states associated to telomere defciency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960 (1999).
23. Blasco, M.A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
24. Muñoz, P., Blanco, R., Flores, J.M. & Blasco, M.A. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat. Genet. 37, 1063-1071 (2005).
25. Blanco, R., Munoz, P., Flores, J.M., Klatt, P. & Blasco, M.A. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 21, 206-220 (2007).
26. Okamoto, K., Iwano, T., Tachibana, M. & Shinkai, Y. Distinct roles of TRF1 in the regulation of telomere structure and lengthening. J. Biol. Chem. 283, 23981-23988 (2008).
27. Sfeir, A. et al. Mammalian telomeres resemble fragile sites and require TRF1 for effcient replication. Cell 138, 90-103 (2009).
28. Martínez, P. et al. Increased telomere fragility and fusions resulting from TRF1 defciency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 23, 2060-2075 (2009).
29. Durkin, S.G. & Glover, T.W. Chromosome fragile sites. Annu. Rev. Genet. 41, 169-192 (2007).
30. d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature, 426, 194-198(2003).
31. Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556 (2003).
32. Bouwman, P. et al. 53BP1 loss rescues BRCA1 defciency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688-695 (2010).
33. Palacios, J. et al. Immunohistochemical characteristics defned by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin. Cancer Res. 9, 3606-3614 (2003).
34. Connor, F. et al. Tumorigenesis and a DNA-repair defect in mice with a truncating BRCA2 mutation. Nat. Genet. 17, 423-430 (1997).
35. Patel, K.J. et al. Involvement of BRCA2 in DNA repair. Mol. Cell 1, 347-357 (1998).
36. Bugreev, D.V., Mazina, O.M. & Mazin, A.V. Rad54 protein promotes branch migration of Holliday junctions. Nature 442, 590-593 (2006).
37. Miller, K.M., Rog, O. & Cooper, J.P. Semi-conservative DNA replication through telomeres requires Taz1. Nature 440, 824-828 (2006).
38. Karlseder, J. Telomeric proteins: clearing the way for the replication fork. Nat. Struct. Mol. Biol. 13, 386-387 (2006).
39. Ye, J. et al. TRF2 and apollo cooperate with topoisomerase 2α to protect human telomeres from replicative damage. Cell 142, 230-242 (2010).
40. Kinzler, K.W. & Vogelstein, B. Cancer-susceptibility genes: gatekeepers and caretakers. Nature 386, 761 (1997).
41. Meeker, A.K. & Argani, P. Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation? J. Mammary Gland Biol. Neoplasia 9, 285-296 (2004).
42. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
43. Dirac, A.M. & Bernards, R. Reversal of senescence in mouse fbroblasts through lentiviral suppression of p53. J. Biol. Chem. 278, 11731-11734 (2003).
44. Thanasoula, M. et al. p53 prevents entry into mitosis with uncapped telomeres. Curr. Biol. 20, 521-526 (2010).
45. Tarsounas, M., Davies, D. & West, S.C. BRCA2-dependent and independent formation of RAD51 nuclear foci. Oncogene 22, 1115-1123 (2003).
46. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J. & Sedivy, J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501-513 (2004).